Kindly MD, Inc.

NAKA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$2,720$3,769$3,787$2,504
% Growth-27.8%-0.5%51.2%
Cost of Goods Sold$83$4,033$4,382$1,589
Gross Profit$2,637-$264-$595$915
% Margin97%-7%-15.7%36.5%
R&D Expenses$378$0$0$0
G&A Expenses$1,907$1,356$6,275$2,356
SG&A Expenses$5,469$1,356$2,098$854
Sales & Mktg Exp.$3,562$0-$4,177-$1,502
Other Operating Expenses$137$0$0$0
Operating Expenses$5,984$1,356$2,098$854
Operating Income-$3,347-$1,620-$2,693$61
% Margin-123.1%-43%-71.1%2.4%
Other Income/Exp. Net-$271$3$153$88
Pre-Tax Income-$3,618-$1,617-$2,541$149
Tax Expense$0$0$0$0
Net Income-$3,618-$1,617-$2,541$149
% Margin-133%-42.9%-67.1%6%
EPS-0.67-0.27-0.430.025
% Growth-148.1%37.2%-1,792.9%
EPS Diluted-0.67-0.27-0.430.025
Weighted Avg Shares Out5,3915,8915,8915,891
Weighted Avg Shares Out Dil5,3915,8915,8915,940
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$393$56$0$0
Depreciation & Amortization$220$203$122$63
EBITDA-$3,004-$1,358-$2,419$125
% Margin-110.4%-36%-63.9%5%
Kindly MD, Inc. (NAKA) Financial Statements & Key Stats | AlphaPilot